Skip to main content
Free research Free research Free target review with research home and workspace preview
Quick search ChEMBL 36
Loading Target Snapshot...
Querying ChEMBL database. This may take a few seconds.
Target Snapshot

CHEMBL2189139 Target Snapshot

Aspartate aminotransferase, cytoplasmic · SINGLE PROTEIN · Homo sapiens

110Compounds
19Assays
6Approved Drugs
113.0Activities
Free Research Context

Research home keeps recent targets

This target will appear in recent viewed items on this browser. Use the demo workspace to preview watch rules and decision queues.

Navigation

Switch target

Move to another high-traffic target or paste a specific ChEMBL target ID.

Broader Open DB context

Frame the target before identity details

Structured disease, protein, and project context should read before the lower-level identity rail.

As of 2026-09-14

Protein identity stays anchored to UniProt P17174. Use UniProt P17174 as the stable identity anchor, then attach disease evidence before program review.

Review focus
Protein anchor ready

Use UniProt P17174 as the stable identity anchor, then attach disease evidence before program review.

ChEMBL component mapping + Open Targets-ready proxy + ChEMBL 36 via Core Engine 2026-09-14
Open source guide
Identity Layer

Cross-source identity

Keep the review anchor, source IDs, and context contract aligned before reusing this target elsewhere.

This review treats Aspartate aminotransferase, cytoplasmic as ChEMBL target CHEMBL2189139, mapped to UniProt P17174. Disease framing currently uses the Open Targets-ready proxy contract.

Review anchor
Aspartate aminotransferase, cytoplasmic
SINGLE PROTEIN · Homo sapiens
As of 2026-09-14
ChEMBL target ID
CHEMBL2189139
Primary anchor for compounds, assays, approvals, and exports
ChEMBL 36 via Core Engine As of 2026-09-14
www.ebi.ac.uk
UniProt accession
P17174
Aspartate aminotransferase, cytoplasmic
UniProt accession via ChEMBL component mapping As of 2026-09-14
www.uniprot.org
Disease evidence contract
Open Targets-ready proxy
ChEMBL drug mechanism + indication proxy
ChEMBL drug mechanism + indication proxy As of 2026-09-14
www.ebi.ac.uk

Reuse the same identifiers in notes, watch rules, exports, and review packs so provenance stays stable across surfaces.

Source Guidance

Start with the right source

Choose the first block or source based on the question you are trying to answer.

Need stable target naming and protein identity?
UniProt Target Context
UniProt accession via ChEMBL component mapping

Start here when your first question is whether Aspartate aminotransferase, cytoplasmic is the right protein anchor across sources, using UniProt P17174 as the stable mapping.

Jump to Protein Context
Need disease fit before discussing compounds?
Disease Relevance & Evidence Level
ChEMBL drug mechanism + indication proxy

Use this block first when you need the strongest disease program and evidence level in one place.

Jump to Disease Context
Need a meeting-ready explanation of why this target matters?
Evidence Card
Review-ready rationale with source-aware context

Open the one-page evidence card when you want the rationale, activity base, and attribution together.

Open Review-ready Card
Overview

Basic Information

Verify identity, organism, and the fastest next research jumps from the same page.

UniProt Context

UniProt Target Context

Reviewable protein naming and mapping context for this target snapshot.

Protein LabelAspartate aminotransferase, cytoplasmic
UniProt AccessionP17174
Component TypeProtein
Sequence Length413 aa

Aspartate aminotransferase, cytoplasmic

Source · UniProt accession via ChEMBL component mapping
Review Cue

How to read this target

Review this target as Aspartate aminotransferase, cytoplasmic, mapped to UniProt P17174. Sequence length is 413 aa.

Mapped IDP17174
Review nameAspartate aminotransferase, cytoplasmic
OrganismHomo sapiens
Clinical Profile

Clinical Phase Distribution

6
Approved
Assay Mix

Activity Type Distribution

IC50108.0
KI2.0
KD3.0
Lead Set

Top Inhibitors (by pChEMBL)

ChEMBL IDpChEMBLTypeValue (nM)Phase
CHEMBL5653589 6.08 Kd 841.98 Preclinical
CHEMBL5182428 5.54 IC50 2920.0 Preclinical
CHEMBL708 5.27 IC50 5390.0 Approved
CHEMBL5170907 5.23 IC50 5910.0 Preclinical
CHEMBL3752910 5.17 Kd 6820.4 Preclinical
CHEMBL5203489 5.1 IC50 8000.0 Preclinical
CHEMBL4238792 5.09 IC50 8200.0 Preclinical
CHEMBL4244961 4.85 IC50 14000.0 Preclinical
CHEMBL542541 4.83 Ki 14740.0 Approved
CHEMBL4237572 4.8 IC50 16000.0 Preclinical
Distribution

pChEMBL Value Distribution

5
5.0
1
5.5
1
6.0
0
6.5
0
7.0
0
7.5
0
8.0
0
8.5
0
9.0
0
9.5
pChEMBL
Assay Landscape

Assay Landscape

19
Total Assays
39
Tested Compounds
1
Assay Types
Binding — 19 assays, 39 compounds
BAO Format Assays Compounds Avg pChEMBL
single protein format 17 36 4.6
cell-based format 2 3 4.7

Confidence Score Distribution

Source · ChEMBL 36 via Core Engine